, suggest that GABAergic regulation of LH secretion may depend on steroid levels (25, 26) . If so, the absence of any significant change in LH secretion following valproate administration in our study of normal women may have been due to the high estradiol and progesterone levels of our subjects, which may have ensured that their basal GABA levels were already high enough to produce the maximum possible effect of GABA on LH secretion (27) .
It is well established that valproate increases hypothalamic concentrations of \g=g\-aminobutyric acid (GABA). Although little research has been done on the role of GABA in the control of pulsatile luteinizing hormone (LH) secretion in humans, our group recently found that administration of valproate had no significant effect on pulsatile LH secretion in late follicular and mid-late luteal phase normal women. However, the results of several studies of rats suggest that GABAergic regulation of LH secretion may depend on steroid levels. The objective of this work was to determine whether regular administration of sodium valproate inhibits pulsatile LH secretion in ovariectomized women. Twelve women who had undergone ovariectomy for causes other than malignant tumors were each studied in two 8 h sessions, in each of which blood samples were taken every 5 min. The first session was the control; for the second, 400 (8, 9) . However, studies in the rat have variously found that the effect of GABA on LH secretion is stimulatory (10, 11) , inhibitory (12, 13) or both (14, 15) .
It is known (16, 17) (19) and an increased release of GABA into the synaptic cleft (20, 21) . We reported recently that alteration of the GABAergic system by sodium valproate had no significant effect on pulsatile LH secretion by normal women during the late follicular phase (22) and mid-late luteal phase (23) . However, the findings in rats that the rise in serum LH concentration following ovariectomy is associated with a fall in hypothalamic GABA levels, and that the fall in serum LH concentration following administration of estradiol is associated with an increase in hypothalamic GABA levels (7, 24) , suggest that GABAergic regulation of LH secretion may depend on steroid levels (25, 26) . If so, the absence of any significant change in LH secretion following valproate administration in our study of normal women may have been due to the high estradiol and progesterone levels of our subjects, which may have ensured that their basal GABA levels were already high enough to produce the maximum possible effect of GABA on LH secretion (27) .
The aim of the study described here was to determine whether valproate-induced alteration of GABA Basal estradiol and progesterone levels were also determined by RIA, using kits from bioMérieux (France); the intra-assay coefficient of variation for estradiol was 6% and for progesterone was 8%. Serum VPA concentrations were determined by repolarization fluorescence spectrophotometry using the Abbott TDX system (sensitivity was 0.7¿¿g/ml and precision was better than 5%).
Signa/ analysis Deconvolution method. To correct for the effect of clearance on serum LH levels (29) and so construct a more faithful picture of the time dependence of actual secretion, the LH data were subjected to a deconvolution procedure (30 
where a¡ in Equation (1) (36) and GnRH receptor gene transcription in the preoptic area and the posterior mediobasal hypothalamus (37) . Because GABA turnover in rat hypothalamus appears to be low in ovariectomized animals (and high in steroid-treated ovariectomized animal) (24), it seems possible that it is precisely this reduction in hypo¬ thalamic GABA that is largely responsible for the high LH secretion of ovariectomized rats (7) .
There has been little direct research on whether GABA plays a role in the regulation of LH secretion in humans (38) (39) (40) (41) . In particular, hardly any work has been done on the possible relationship ofthe GABAergic system to the pulsatility of LH secretion (22, 23, 42 (48) and steroid levels (which are constant in ovariectomized women) (49).
It seems unlikely that our negative results can have been due simply to VPA having had little effect on hypothalamic GABA concentration; although GABA was not determined in this study, it is well established that the VPA dosage used in this work increases GABA levels both in plasma (by 33-80% within 48-72h (50) (51) (52) ) and in various cerebral nuclei (17, 53) , especially hypothalamus (by 95% (18) 
